ஏகாதிபத்தியம் மருத்துவ ஆராய்ச்சி வசதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஏகாதிபத்தியம் மருத்துவ ஆராய்ச்சி வசதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஏகாதிபத்தியம் மருத்துவ ஆராய்ச்சி வசதி Today - Breaking & Trending Today

The Magic in 'Magic Mushrooms': Can Psilocybin Make a Mark in Depression Tx?

The Magic in 'Magic Mushrooms': Can Psilocybin Make a Mark in Depression Tx?
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

New York , United States , New York State Psychiatric Institute , City Of , United Kingdom , Jeffreya Lieberman , Robin Carhart Harris , John Mckenna , Synthesis Institute , Alexander Mosley Charitable , Imperial Clinical Research Facility , Imperial Biomedical Research Centre , Imperial College London , Imperial College London Centre For Psychedelic Research , York State Psychiatric Institute , Columbia University Vagelos College Of Physicians , Usona Institute , New England Journal , Columbia University Vagelos College , Associate Editor , Alexander Mosley Charitable Trust , Biomedical Research Centre , Clinical Research , Entheon Biomedical , Tryp Therapeutics , புதியது யார்க் ,

Magic mushroom compound performs at least as well as leading antidepressant in small study

Credit: Imperial College London / Thomas Angus
Psilocybin, the active compound in magic mushrooms, may be at least as effective as a leading antidepressant medication in a therapeutic setting.
This is the finding of a study carried out by researchers at the Centre for Psychedelic Research at Imperial College London.
In the most rigorous trial to date assessing the therapeutic potential of a psychedelic compound, researchers compared two sessions of psilocybin therapy with a six-week course of a leading antidepressant (a selective serotonin uptake inhibitor called escitalopram) in 59 people with moderate-to-severe depression.
The results, published today in the
New England Journal of Medicine, show that while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and were greater in magnitude. ....

United Kingdom , City Of , Rosalind Watts , Robin Carhart Harris , David Nutt , Edmondj Safra , Imperial College London , Alexander Mosley Charitable , Imperial Clinical Research Facility , Centre For Psychedelic Research , Centre For Psychedelic Research At Imperial , Imperial Biomedical Research Centre , Psychedelic Research , Imperial College , New England Journal , Edmondj Safra Chair , Alexander Mosley Charitable Trust , Biomedical Research Centre , Clinical Research , College London , Times Higher Education , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ரோசாலிண்ட் வாட்ஸ் , ராபின் கார்ஹார்ட் ஹாரிஸ் , டேவிட் நட் ,